LubeluzoleAlternative Names: JK 8792; Prosynap; R 87926
Latest Information Update: 03 Apr 2001
$50 / €47 *
At a glance
- Originator Janssen L.P.
- Developer Janssen Pharmaceutical KK
- Class Anti-ischaemics; Neuroprotectants; Piperidines; Small molecules; Thiazoles
- Mechanism of Action Glutamate receptor antagonists; Nitric oxide inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke